S1P, Generated by Sphingosine Kinase 1, Negatively Affects Corneal Wound Healing Process by Activating TGF-β/Smad

Sandip K Basu1, Sarah E Nicholas2,3, Bradley P Hambly1

  • 1Department of Ophthalmology, University of Tennessee Health Science Center, Memphis 38163, Tennessee, USA, tennessee.edu.

Insights

Inhibition of sphingosine-1-phosphate (S1P) signaling accelerates corneal wound healing. Reducing S1P signaling in mice enhanced epithelial closure and reduced fibrosis after injury, suggesting a therapeutic target for corneal opacity.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Corneal opacity, a leading cause of blindness, results from abnormal healing of corneal injuries.
  • Complex signaling pathways govern corneal healing, and a lack of understanding hinders therapeutic development.
  • Sphingosine-1-phosphate (S1P) and transforming growth factor beta (TGFβ) signaling are implicated in tissue fibrosis.

Purpose of the Study:

  • To elucidate the interplay between S1P and TGFβ signaling in corneal wound healing and fibrosis.
  • To determine the role of sphingosine kinase 1 (SphK1) in modulating these pathways.

Main Methods:

  • Corneal alkali burn injury was induced in Sphingosine kinase 1 gene knockout (Sphk1-/-) mice and wildtype littermates.
  • Wound healing, TGFβ signaling intermediates, and profibrotic protein expression were assessed at various days postinjury.
  • Exogenous SphK1 inhibition was tested in wildtype mice.

Main Results:

  • Sphk1-/- mice exhibited accelerated corneal epithelial closure compared to wildtype controls.
  • Reduced activation of Smad2/3 and altered expression of Smad4 and Smad7 were observed in Sphk1-/- mice.
  • Pharmacological inhibition of SphK1 accelerated wound healing in wildtype mice.

Conclusions:

  • S1P signaling positively influences TGFβ pathways, delaying corneal wound healing and promoting fibrosis.
  • Inhibition of S1P signaling accelerates corneal wound healing and may prevent fibrosis and scar formation.
  • Targeting S1P signaling presents a potential therapeutic strategy for corneal injury recovery.